Skip to main content

Table 3 Description of prevalence of each subset

From: Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome

Number of subsets

Subset A

Subset B

Subset C

2

0.2

0.8

 
 

0.4

0.6

 
 

0.6

0.4

 
 

0.8

0.2

 

3

1/3

1/3

1/3

 

1/6

1/3

2/4

 

11/18

1/3

1/18

 

1/3

2/4

1/6

 

1/3

1/18

11/18

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us